Get the latest Science News and Discoveries

MDMA therapies hit a roadblock – what's next?


The US Food and Drug Administration has rejected the psychedelic drug MDMA as a treatment for post-traumatic stress disorder, leading many to wonder whether psychedelic therapies have a future in medicine

None

Get the Android app

Or read this on New Scientist

Read more on:

Photo of roadblock

roadblock

Photo of MDMA therapies

MDMA therapies

Photo of MDMA

MDMA

Related news:

News photo

FDA rejected MDMA-assisted PTSD therapy. Other psychedelics firms intend to avoid that fate

News photo

The FDA Just Rejected a Bid for MDMA to Treat PTSD

News photo

Veterans and Lawmakers Lobby for Approval of MDMA Therapy